Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1944 of 6351
-
Smartphone program aims to help HIV patients kick the habit
Disease control OngoingThis study will evaluate if Automated Treatment performs better, in terms of facilitating long-term smoking abstinence, than the more resource-intensive Standard Treatment.
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New radiation combo aims to boost immunotherapy in advanced lung cancer
Disease control OngoingThis pilot phase I trial aims to investigate the safety and tolerability of low dose radiotherapy (LDRT) and concurrent partial stereotactic body radiation therapy (SBRT) in combination with programmed cell death-1 (PD-1) inhibitors in Stage IV non-small cell lung cancer (NSCLC) …
Phase 1 • Sponsor: Sichuan University • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Blood test may spot hidden cancer DNA after surgery
Knowledge-focused OngoingThe CORRECT - MRD II study will prospectively enroll patients who have undergone complete surgical resection for stage II or III colorectal cancer. Maximum duration of participant participation is up to seven years from enrollment to study completion with up to five years of acti…
Sponsor: Exact Sciences Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
New digital platform aims to catch Alzheimer's before symptoms worsen
Diagnosis Recruiting nowThe aging population in Europe is leading to an increase in neurodegenerative diseases, such as Alzheimer's disease (AD), which is expected to affect 152 million people worldwide by 2050. In Italy, there are approximately 1.2 million cases of dementia, with 600,000 attributed to …
Sponsor: IRCCS San Raffaele • Aim: Diagnosis
Last updated Jun 27, 2026 08:12 UTC
-
New drug combo shows promise against rare eye cancer
Disease control OngoingThis research study is investigating Binimetinib and Belinostat in participants with metastatic uveal melanoma. The research study will test the study drugs to see if the combination of binimetinib and belinostat can make tumors shrink or stop growing.
Phase 2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Your phone could reward you for not smoking: app locks apps until you pass a breath test
Disease control CompletedThis series of studies will explore the acceptability, feasibility, and preliminary efficacy of making access to smartphone applications contingent on objective evidence of smoking abstinence.
Sponsor: Rowan University • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
New radiation approach could cut treatment time for rare skin cancer
Disease control Recruiting nowThis phase II trial tests whether hypofractionated radiation works to treat patients with Merkel cell carcinoma. Radiation therapy uses high energy radio waves to kill cancer cells and shrink tumors. Hypofractionated radiation therapy delivers higher doses of radiation therapy ov…
Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Dutch study tracks COVID antivirals in High-Risk patients
Knowledge-focused CompletedNovel antiviral drugs can mark a turning point in the prevention and treatment of patients with Covid-19. Recently, several independent large phase-III RCTs have shown that the intravenous administration of one gift of neutralizing SARS-CoV-2 monoclonal antibodies can reduce the …
Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC
-
New drug combo aims to shrink hard-to-treat tumors
Disease control Recruiting nowThis is a multicenter Phase 1b, open label, dose-escalation and cohort-expansion study, evaluating the safety, tolerability, pharmacokinetics (PK), preliminary antitumor activity, and effect of biomarkers of zanzalintinib administered alone, and in combination with nivolumab (dou…
Phase 1 • Sponsor: Exelixis • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
MIND diet may shield stroke survivors from dementia
Prevention OngoingTo test the effects of a 2- to 3-year intervention of the MIND diet versus usual post-stroke care on cognitive decline, the characteristic feature of dementia, and on brain biomarkers of Alzheimer's Disease (AD) and vascular disease in a Phase Ill randomized controlled trial of 2…
Sponsor: Rush University Medical Center • Aim: Prevention
Last updated Jun 27, 2026 12:23 UTC
-
New pill combo shows promise for older myeloma patients
Disease control OngoingThis is a phase II, multicenter, open-label study to evaluate the rate of patients achieving very good partial response (VGPR) or better to the oral combination Iberdomide Ixazomib Dexamethasone in elderly patients with multiple myeloma at first relapse . The patient population …
Phase 2 • Sponsor: Nantes University Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a common spice change how drugs work in your body?
Knowledge-focused CompletedThe purpose of this study is to evaluate a well-characterized, commercially available cinnamon dietary supplement as a precipitant of pharmacokinetic interactions with cytochrome P450 (CYP) 2A6 drug substrates in healthy volunteers. Nicotine gum will be used as the CYP2A6 probe d…
Early phase 1 • Sponsor: Washington State University • Aim: Knowledge-focused
Last updated Aug 26, 2026 00:00 UTC
-
Could a menopause drug combo cut breast cancer risk?
Prevention OngoingWomen at risk for development of breast cancer and experiencing vasomotor menopausal symptoms (hot flashes) will be randomized to bazedoxifene (BZA) plus conjugated estrogens (CE) for 6 months versus a wait list control. Two risk factors for development of breast cancer will be s…
Phase 2 • Sponsor: University of Kansas Medical Center • Aim: Prevention
Last updated Jun 27, 2026 07:56 UTC
-
New program aims to stop post-surgery confusion in seniors
Prevention Recruiting nowCognitive complications, that is problems with thinking and memory, are incredibly common after surgery, occurring in 10-50% of all older surgical patients. These complications can take different forms, but one of the most common is postoperative delirium (POD), a short-term stat…
Sponsor: Sunnybrook Health Sciences Centre • Aim: Prevention
Last updated Jun 26, 2026 15:51 UTC
-
Ear stimulation device could ease endometriosis pain
Symptom relief Recruiting now6-10% of women of childbearing age suffer from endometriosis, which is mainly manifested by dysmenorrhea, non-menstrual pelvic pain and dyspareunia. Several treatment strategies, including surgical ones, are proposed but they are sometimes insufficient because endometriosis-relat…
Sponsor: Hopital Foch • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
New RNA vaccine takes on deadly brain cancers in kids and adults
Disease control Recruiting nowThe primary objective will be to demonstrate the manufacturing feasibility and safety, and to determine the maximum tolerated dose (MTD) of RNA-LP vaccines in (Stratum 1) adult patients with newly diagnosed GBM (MGMT low level or unmethylated in adults only) and (Stratum 2) in pe…
Phase 1 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New eczema drug shows promise in long-term real-world study
Disease control OngoingAtopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Therapies spread over the skin may not be enough to control the AD in trial participants who require systemic anti-inflammatory treatment. This study will assess the real…
Sponsor: AbbVie • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC
-
Nasal spray could tame racing heart episodes at home
Symptom relief CompletedThis Open Label Extension study will enable eligible patients with Paroxysmal Supraventricular Tachycardia (PSVT) who have previously participated in a Milestone Pharmaceuticals clinical trial of etripamil NS for PSVT, to access continued treatment with etripamil NS, Patients who…
Phase 3 • Sponsor: Milestone Pharmaceuticals Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
New imaging showdown: can MBI replace MRI for High-Risk breast cancer detection?
Diagnosis Recruiting nowTo evaluate the diagnostic performance of Tc99m sestamibi (MBI) compared to breast MRI in women who are at high risk for developing breast cancer. To assess the relationship of tumor size, histologic subtype and location of lesion and how it affects lesion conspicuity and sensit…
Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:07 UTC
-
Can a 16-Week family program stop diabetes in latino teens?
Prevention OngoingPurpose: This study will test the efficacy of a family-focused lifestyle intervention for reducing type 2 diabetes (T2D) risk factors and increasing Quality of Life (QoL) among high-risk Latino families.
Sponsor: Arizona State University • Aim: Prevention
Last updated Jun 27, 2026 12:25 UTC